Clinical Services

Geography determines survival of babies with birth defects

21 July, 2021

A global study involving 74 countries has found that the survival rate of babies born with a birth defect is heavily dependent on where the child is born.


Development of blood vessel repair therapy accelerated

19 July, 2021

UniQuest has partnered with CSL to accelerate the development of a potential treatment for the repair of blood vessels damaged by inflammation.


Responding to COVID in a midwifery setting in South Australia

19 July, 2021 by Julie Tucker*

Midwife Julie Tucker, from Lyell McEwin Hospital in Adelaide, provides a snapshot of changes made to maternity care as a result of COVID-19.


Hospital pharmacy performing under pressure as mass vaccination gains momentum

13 July, 2021 by Kristin Michaels, SHPA CEO

Hospital pharmacists and technicians find themselves at the very centre of the largest public health initiative in Australia's history.


Medicinal cannabis facility planned for Toowoomba

12 July, 2021

Medibis has announced long-term plans to build a multi-million-dollar medicinal cannabis facility in Toowoomba, Queensland.


'Spider web' mechanism traps and kills viruses

12 July, 2021

Immunologists at Canada's McMaster University have discovered a mechanism that acts like a spider web — trapping and killing pathogens such as influenza or SARS-CoV-2.


PBS listing for ulcerative colitis treatment

05 July, 2021

Australians living with moderate-to-severe ulcerative colitis can now access a PBS-listed oral treatment alternative.


Whiteley Surfex dry-surface biofilm remover and disinfectant

01 July, 2021 | Supplied by: Whiteley

Surfex from Whiteley Medical is a dry-surface biofilm remover and disinfectant, intended for use on environmental surfaces and for non-critical medical devices such as hospital beds and theatre trolleys.


New treatment for asbestos-related cancer

01 July, 2021

Australians living with inoperable malignant mesothelioma will soon have access to an immunotherapy listed on the Pharmaceutical Benefits Scheme.


CleanSpace Technology CleanSpace Respirators

01 July, 2021 | Supplied by: CleanSpace Technology Pty Ltd

CleanSpace Technology's CleanSpace Respirators are designed to protect healthcare workers from airborne contaminants.


Global collaboration strives to advance heart health

30 June, 2021

The Global Cardiovascular Research Funders Forum aims to to advance the prevention, diagnosis and treatment of cardiovascular conditions such as heart attack and stroke.


What's Australia's first local Pfizer-style COVID vaccine? And when might it be in our arms? An mRNA expert explains

25 June, 2021 by Archa Fox Associate Professor and ARC Future Fellow, The University of Western Australia

A research team at Monash University hopes to develop a new mRNA vaccine, which works by the same principles as the Pfizer vaccine and could be manufactured locally.


Flinders University joins male health research alliance

23 June, 2021

Flinders University has become a research partner of the Freemasons Centre for Male Health & Wellbeing, broadening the scope and footprint of the centre's activities.


Fish oil's role in stopping superbugs

22 June, 2021

Australian scientists have discovered that regular fish oil has the potential to break down superbugs' ability to become resistant to antibiotics.


PanKind initiative sets sights on early detection of pancreatic cancer

21 June, 2021

PanKind has launched the PanKind Early Detection Initiative in a move to strategically work with the research community to improve early diagnosis of pancreatic cancer.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd